Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes

PURPOSE: Improved understanding of characteristics that may influence treatment response across phenotypes may help guide treatment decisions. PATIENTS AND METHODS: This was a post hoc analysis of MENSA, a multicenter, randomized, double-blind, placebo-controlled trial (NCT01691521). Patients aged ≥...

Descripción completa

Detalles Bibliográficos
Autores principales: Prazma, Charlene M, Idzko, Marco, Douglass, Jo Anne, Bourdin, Arnaud, Mallett, Stephen, Albers, Frank C, Yancey, Steven W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214022/
https://www.ncbi.nlm.nih.gov/pubmed/34163180
http://dx.doi.org/10.2147/JAA.S298559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214022/
https://www.ncbi.nlm.nih.gov/pubmed/34163180
http://dx.doi.org/10.2147/JAA.S298559

Ejemplares similares